Heparanase: A Novel Therapeutic Target for the Treatment of Atherosclerosis

Cardiovascular disease (CVD) is the leading cause of death and disability worldwide, and its management places a huge burden on healthcare systems through hospitalisation and treatment. Atherosclerosis is a chronic inflammatory disease of the arterial wall resulting in the formation of lipid-rich, f...

Full description

Bibliographic Details

Published in:	Cells
Main Authors:	Tien K. Nguyen, Stephanie Paone, Enoch Chan, Ivan K. H. Poon, Amy A. Baxter, Shane R. Thomas, Mark D. Hulett
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Subjects:	heparanase heparan sulfate extracellular matrix (ECM) atherosclerosis inflammation immune cells
Online Access:	https://www.mdpi.com/2073-4409/11/20/3198